Viewing data from:

RISEDRONATE SODIUM

ANDA

RISEDRONATE SODIUM | A090877 | APOTEX INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: ACTONEL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$12.82

per ea

Lowest NADAC/Unit

$2.01

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
60505309702RISEDRONATE SODIUM 150 MG TAB	$12.82	EA	Generic	—	2026-08-19
60505309704RISEDRONATE SODIUM 150 MG TAB	$12.82	EA	Generic	—	2026-08-19
60505316500RISEDRONATE SODIUM 35 MG TABLET	$2.01	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$16.63

Highest Price

$197.49

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
60505-3097-02RISEDRONATE NA 150MG TAB	$20.51	FSS	Golden State Medical Supply, Inc.	06/14/2028
60505-3097-04RISEDRONATE NA 150MG TAB	$197.49	FSS	Golden State Medical Supply, Inc.	06/14/2028
60505-3165-00RISEDRONATE NA 35MG TAB	$16.63	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain12 active DMFs5 inactive

12 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVRISEDRONATE SODIUM

DMF 166042003

JUBILANT BIOSYS LTDRISEDRONATE SODIUM HEMIPENTAHYDRATE-USP

DMF 199682006

CIPLA LTDRISEDRONATE SODIUM HEMI PENTAHYDRATE USP

DMF 201622007

MATRIX PHARMACORP PRIVATE LTDRISEDRONATE SODIUM USP (HEMI-PENTAHYDRATE)

DMF 203982007

SYNTHIMED LABS PRIVATE LTDRISEDRONATE SODIUM HEMIPENTAHYDRATE USP

DMF 210332007

APITORIA PHARMA PRIVATE LTDRISEDRONATE SODIUM HEMIPENTAHYDRATE USAP (NON-STERILE DRUG SUBSTANCE)

DMF 211212007

SUN PHARMACEUTICAL INDUSTRIES LTDRISEDRONATE SODIUM HEMI-PENTAHYDRATE USP

DMF 215292008

APOTEX INCRISEDRONATE SODIUM HEMIPENTAHYDRATE USP

DMF 218192008

MACLEODS PHARMACEUTICALS LTDRISEDRONATE SODIUM

DMF 237382010

ALCHYMARS ICM SM PRIVATE LTDRISEDRONATE SODIUM USP

DMF 245912011

ORBION PHARMACEUTICALS PRIVATE LTDRISEDRONATE SODIUM

DMF 257682012

IPCA LABORATORIES LTDRISEDRONATE SODIUM HEMI-PENTAHYDRATE USP

DMF 272522013

DIVIS LABORATORIES LTDInactiveRISEDRONATE SODIUM

DMF 188072005

DR REDDYS LABORATORIES LTDInactiveRISEDRONATE SODIUM HEMIPENTAHYDRATE

DMF 214472008

IPCA LABORATORIES LTDInactiveRISEDRONATE SODIUM HEMI-PENTAHYDRATE USP

DMF 237592010

PHARMAZELL VIZAG PRIVATE LTDInactiveRISEDRONATE SODIUM HEMIPENTAHYDRATE USP

DMF 250072011

HETERO DRUGS LTDInactiveRISEDRONATE SODIUM HEMI-PENTAHYDRATE, USP

DMF 271972013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 35MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 30, 2015

No patent or exclusivity listings for this strength.

#002 — 75MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 10, 2014

#003 — 150MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 10, 2014